InterMune

URI: https://gptkb.org/entity/InterMune
GPTKB entity
Statements (20)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Roche
gptkbp:acquisitionYear 2014
gptkbp:CEO gptkb:Dan_Welch
gptkbp:country gptkb:United_States
gptkbp:focusesOn orphan drugs
pulmonary diseases
gptkbp:foundedIn 1998
gptkbp:founder gptkb:Scott_Harkonen
gptkbp:headquartersLocation gptkb:Brisbane,_California,_United_States
https://www.w3.org/2000/01/rdf-schema#label InterMune
gptkbp:indication idiopathic pulmonary fibrosis
gptkbp:industry gptkb:biotechnology
gptkbp:notableProduct gptkb:pirfenidone
gptkbp:productApprovedBy gptkb:FDA
gptkb:European_Medicines_Agency
gptkbp:stockSymbol gptkb:ITMN
gptkbp:tradedOn gptkb:NASDAQ
gptkbp:bfsParent gptkb:Amphotec
gptkbp:bfsLayer 7